Study partners: essential collaborators in discovering treatments for Alzheimer’s disease

[1]  H. Lynch,et al.  Addressing Financial Barriers to Enrollment in Clinical Trials. , 2018, JAMA oncology.

[2]  P. Rabins,et al.  Study partners perform essential tasks in dementia research and can experience burdens and benefits in this role , 2018, Dementia.

[3]  I. Cohen,et al.  A Framework for Ethical Payment to Research Participants , 2018, The New England journal of medicine.

[4]  H. Lynch,et al.  Paying Research Participants: The Outsized Influence of "Undue Influence". , 2017, IRB.

[5]  Jared A. Rowland,et al.  Neuropsychological Test Administration by Videoconference: A Systematic Review and Meta-Analysis , 2017, Neuropsychology Review.

[6]  J. Karlawish,et al.  Unfinished Business in Preventing Alzheimer Disease. , 2016, JAMA internal medicine.

[7]  M. Weiner,et al.  The crisis in recruitment for clinical trials in Alzheimer's and dementia: An action plan for solutions , 2016, Alzheimer's & Dementia.

[8]  E. Teng,et al.  African Americans are less likely to enroll in preclinical Alzheimer's disease clinical trials , 2016, Alzheimer's & dementia.

[9]  Roy W Jones,et al.  Drug development in Alzheimer’s disease: the path to 2025 , 2016, Alzheimer's Research & Therapy.

[10]  R. Banzi,et al.  Older patients are still under-represented in clinical trials of Alzheimer’s disease , 2016, Alzheimer's Research & Therapy.

[11]  R. Banzi,et al.  Older patients are still under-represented in clinical trials of Alzheimer’s disease , 2016, Alzheimer's Research & Therapy.

[12]  P. Doraiswamy,et al.  Underrepresentation of African-Americans in Alzheimer's Trials: A Call for Affirmative Action , 2016, Front. Aging Neurosci..

[13]  Hang Lee,et al.  Financial Burden of Cancer Clinical Trial Participation and the Impact of a Cancer Care Equity Program. , 2016, The oncologist.

[14]  Alzheimer’s Association,et al.  2016 Alzheimer's disease facts and figures , 2016, Alzheimer's & Dementia.

[15]  M. Prince,et al.  World Alzheimer Report 2015 - The Global Impact of Dementia: An analysis of prevalence, incidence, cost and trends , 2015 .

[16]  J. Karlawish,et al.  Frequency and Impact of Informant Replacement in Alzheimer Disease Research , 2015, Alzheimer disease and associated disorders.

[17]  David S. Miller,et al.  Comparing recruitment, retention, and safety reporting among geographic regions in multinational Alzheimer’s disease clinical trials , 2015, Alzheimer's Research & Therapy.

[18]  Sirpa Hartikainen,et al.  Systematic Review: Representativeness of Participants in RCTs of Acetylcholinesterase Inhibitors , 2015, PloS one.

[19]  Sasha Colby,et al.  Projections of the Size and Composition of the U.S. Population: 2014 to 2060. Population Estimates and Projections. Current Population Reports. P25-1143. , 2015 .

[20]  J. Karlawish,et al.  Why are Spousal Caregivers More Prevalent than Nonspousal Caregivers as Study Partners in AD Dementia Clinical Trials? , 2015, Alzheimer disease and associated disorders.

[21]  P. Rabins,et al.  Researchers’ perspectives on the role of study partners in dementia research , 2014, International Psychogeriatrics.

[22]  Laurie M. Ryan,et al.  Obstacles and opportunities in Alzheimer's clinical trial recruitment. , 2014, Health affairs.

[23]  Travis J. Beaulieu,et al.  Economic analysis of opportunities to accelerate Alzheimer’s disease research and development , 2014, Annals of the New York Academy of Sciences.

[24]  J. Kimmelman,et al.  The questionable use of unequal allocation in confirmatory trials , 2014, Neurology.

[25]  Paco Martorell,et al.  Monetary costs of dementia in the United States. , 2013, The New England journal of medicine.

[26]  J. Karlawish,et al.  Effect of study partner on the conduct of Alzheimer disease clinical trials , 2013, Neurology.

[27]  Dongwen Wang,et al.  Willingness of Parkinson's disease patients to participate in research using internet-based technology. , 2012, Telemedicine journal and e-health : the official journal of the American Telemedicine Association.

[28]  R. Little,et al.  The prevention and treatment of missing data in clinical trials. , 2012, The New England journal of medicine.

[29]  J. Karlawish,et al.  Are Patients Whose Study Partners Are Spouses More Likely to be Eligible for Alzheimer’s Disease Clinical Trials , 2012, Dementia and Geriatric Cognitive Disorders.

[30]  L. Fogarty,et al.  Decision making for participation in dementia research. , 2012, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[31]  Denise C. Park,et al.  Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.

[32]  J. Karlawish,et al.  Addressing the challenges to successful recruitment and retention in Alzheimer's disease clinical trials , 2010, Alzheimer's Research & Therapy.

[33]  M. Sano,et al.  The net effect of alternative allocation ratios on recruitment time and trial cost , 2009, Clinical trials.

[34]  J. Karlawish,et al.  How redesigning AD clinical trials might increase study partners’ willingness to participate , 2008, Neurology.

[35]  A. Zaslavsky,et al.  Randomized Trial of $20 Versus $50 Incentives to Increase Physician Survey Response Rates , 2008, Medical care.

[36]  A. Stewart,et al.  RACE/ETHNIC DIFFERENCES IN AD SURVIVAL IN US ALZHEIMER'S DISEASE CENTERS , 2008, Neurology.

[37]  J. Varni,et al.  Costs of recruiting couples to a clinical trial. , 2007, Contemporary clinical trials.

[38]  E. Emanuel,et al.  Are Racial and Ethnic Minorities Less Willing to Participate in Health Research? , 2005, PLoS medicine.

[39]  J. Grace,et al.  Validity of Informant Reports About AD and MCI Patients’ Memory , 2004, Alzheimer disease and associated disorders.

[40]  K. Maschke,et al.  National practices regarding payment to research subjects for participating in pediatric research. , 2002, Pediatrics.

[41]  C. Grady,et al.  The ethics of paying for children's participation in research. , 2002, The Journal of pediatrics.

[42]  J. Karlawish,et al.  The continuing unethical conduct of underpowered clinical trials. , 2002, JAMA.

[43]  J. Karlawish,et al.  How do AD patients and their caregivers decide whether to enroll in a clinical trial? , 2001, Neurology.

[44]  B. Tarlow,et al.  The Cost of Recruiting Alzheimer’s Disease Caregivers for Research , 2000, Journal of aging and health.

[45]  T. Treves,et al.  Demented patients' participation in a clinical trial: factors affecting the caregivers' decision , 2000, International journal of geriatric psychiatry.

[46]  C. Grady,et al.  What's the price of a research subject? Approaches to payment for research participation. , 1999, The New England journal of medicine.

[47]  D. Knopman,et al.  The Clinician Interview‐ Based Impression (CIBI) , 1994, Neurology.

[48]  D. Gillen,et al.  Constructing a Local Potential Participant Registry to Improve Alzheimer's Disease Clinical Research Recruitment. , 2018, Journal of Alzheimer's disease : JAD.

[49]  E. Largent,et al.  Paying Research Participants: Regulatory Uncertainty, Conceptual Confusion, and a Path Forward. , 2018, Yale journal of health policy, law, and ethics.

[50]  C. Jack,et al.  Framework : Towards a Biological Definition of Alzheimer ’ s Disease 1 2 draft 9-19-17 3 4 5 , 2017 .

[51]  C. V. Van Houtven,et al.  The effect of informal care on work and wages. , 2013, Journal of health economics.